Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

This study is a multicenter, prospective cohort study designed to systematically evaluate the clinical efficacy of integrated Traditional Chinese and Western Medicine on short-term functional improvement in patients with ankylosing spondylitis, with the Bath Ankylosing Spondylitis Functional Index (BASFI) at 6 months of treatment as the primary outcome measure.

NCT Number	NCT07556224
Lead Sponsor	China-Japan Friendship Hospital Collaborators: The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Guangxi Ruikang Hospital, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Beijing Electric Power Hospital, Hunan University of Traditional Chinese Medicine, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Xi'an Fifth Hospital, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital
Conditions	Ankylosing Spondylitis (AS)
Enrollment	790 participants
Start Date	2026-01-19
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-29